Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2011

01.02.2011

Consanguinity Rate and Delay in Diagnosis in Turkish Patients with Combined Immunodeficiencies: a Single-Center Study

verfasst von: Elif Azarsiz, Nesrin Gulez, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Combined immunodeficiency diseases comprise a group of disorders with different molecular basis. Clinical and immunological phenotypes for each group are extremely heterogenous. The frequency of combined immunodeficiencies may vary in different countries. The most frequent forms of combined immunodeficiency show inherited defects in development of T and/or B lymphocytes. These defects are classified according to immunologic phenotype and are categorized into T−B+ or T−B− including forms with or without natural killer lymphocytes. We report here twenty-three patients (female/male: 12/11) with combined immunodeficiency showing different immunological and clinical phenotypes, majority of whom were admitted because of severe upper and lower respiratory tract infections. Mean age of the study group, mean age at onset of the symptoms, and diagnosis were 47.5 ± 42.2, 11.2 ± 17.3, and 19.5 ± 23.8 months, respectively. There was nearly 8 months time delay between beginning of symptoms and diagnosis. Within the combined immunodeficiency phenotypes, T−B−NK+ category was the most frequent phenotype. Consanguinity was positive in 73.9% (n = 17) of patients while it was about 80.0% (n = 8) in deceased ten children. Bone marrow or umblical cord stem cell transplantation was applied to 11 of them. Three patients deceased after transplantation and seven patients deceased without transplantation. Twelve patients are being followed by prophylactic treatment. In conclusion; combined immunodeficiencies are frequent in our country because of high rate of consanguinity. T−B− combined immunodeficiencies are more often observed, and infants presenting severe infections beginning in the first 3 months of life have to be examined for combined immunodeficiencies. Shortening of time delay in diagnosis will increase success of life-saving treatment.
Literatur
1.
Zurück zum Zitat Notarangelo LD. Primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 2010;125:S182–94.CrossRefPubMed Notarangelo LD. Primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 2010;125:S182–94.CrossRefPubMed
2.
Zurück zum Zitat Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. The Journal of Allergy and Clinical Immunology. 2009;124:1161–78.CrossRefPubMed Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. The Journal of Allergy and Clinical Immunology. 2009;124:1161–78.CrossRefPubMed
3.
Zurück zum Zitat Van der Burg M, Van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, et al. A new type of radiosensitive T−B−NK+ severe combined immunodeficiency caused by a LIG4 mutation. Journal of Clinical Investigation. 2006;116:137–45.CrossRefPubMed Van der Burg M, Van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, et al. A new type of radiosensitive T−B−NK+ severe combined immunodeficiency caused by a LIG4 mutation. Journal of Clinical Investigation. 2006;116:137–45.CrossRefPubMed
4.
Zurück zum Zitat Van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, et al. A DNA-PKcs mutation in a radiosensitive T−B− SCID patient inhibits Artemis activation and nonhomologous end-joining. Journal of Clinical Investigation. 2009;119:91–8.PubMed Van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, et al. A DNA-PKcs mutation in a radiosensitive T−B− SCID patient inhibits Artemis activation and nonhomologous end-joining. Journal of Clinical Investigation. 2009;119:91–8.PubMed
5.
Zurück zum Zitat Buck D, Malivert L, de Chasseval R, Barraud A, Fondanèche MC, Sanal O, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.CrossRefPubMed Buck D, Malivert L, de Chasseval R, Barraud A, Fondanèche MC, Sanal O, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.CrossRefPubMed
6.
Zurück zum Zitat Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genetics. 2009;41:101–5.CrossRefPubMed Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genetics. 2009;41:101–5.CrossRefPubMed
7.
Zurück zum Zitat Kalman L, Lindegren ML, Kobrynsk L, Vogt R, Hannon H, Howard JT, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genetics in Medicine. 2004;6(1):16–26.CrossRefPubMed Kalman L, Lindegren ML, Kobrynsk L, Vogt R, Hannon H, Howard JT, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genetics in Medicine. 2004;6(1):16–26.CrossRefPubMed
8.
Zurück zum Zitat Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary İmmunodeficiency Registry. Journal of Clinical Immunology. 2006;26:519–32.CrossRefPubMed Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary İmmunodeficiency Registry. Journal of Clinical Immunology. 2006;26:519–32.CrossRefPubMed
9.
Zurück zum Zitat Al-Atatas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. Journal of Clinical Immunology. 1998;18:368–71.CrossRef Al-Atatas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. Journal of Clinical Immunology. 1998;18:368–71.CrossRef
10.
Zurück zum Zitat Al-Herz W. Primary ımmunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004–2006). Journal of Clinical Immunology. 2008;28:186–93.CrossRefPubMed Al-Herz W. Primary ımmunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (20042006). Journal of Clinical Immunology. 2008;28:186–93.CrossRefPubMed
11.
Zurück zum Zitat Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. Journal of Clinical Immunology. 1988;8:479–85.CrossRefPubMed Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. Journal of Clinical Immunology. 1988;8:479–85.CrossRefPubMed
12.
Zurück zum Zitat Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. The Journal of Allergy and Clinical Immunology. 1997;100:415–23.CrossRefPubMed Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. The Journal of Allergy and Clinical Immunology. 1997;100:415–23.CrossRefPubMed
13.
Zurück zum Zitat Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary ımmunodeficiency diseases in the Turk ethnic group, living in the Northwestern Iran. Journal of Clinical Immunology. 2007;27:5.CrossRef Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary ımmunodeficiency diseases in the Turk ethnic group, living in the Northwestern Iran. Journal of Clinical Immunology. 2007;27:5.CrossRef
14.
Zurück zum Zitat Reda SM, Afifi HM, Amine MM. Primary ımmunodeficiency diseases in Egyptian children: a single-center study. Journal of Clinical Immunology. 2009;29:343–51.CrossRefPubMed Reda SM, Afifi HM, Amine MM. Primary ımmunodeficiency diseases in Egyptian children: a single-center study. Journal of Clinical Immunology. 2009;29:343–51.CrossRefPubMed
15.
Zurück zum Zitat Aksu G, Kutukculer N, Genel F, Koturoglu G, Kurugol Z. Serum immunoglobulin (IgG, A, M) and IgG subclass concentrations in healthy children: a study using nephelometric technique. The Turkish Journal of Pediatrics. 2006;48:19–24.PubMed Aksu G, Kutukculer N, Genel F, Koturoglu G, Kurugol Z. Serum immunoglobulin (IgG, A, M) and IgG subclass concentrations in healthy children: a study using nephelometric technique. The Turkish Journal of Pediatrics. 2006;48:19–24.PubMed
16.
Zurück zum Zitat Ikincioğulları A, Kendirli T, Doğu F. Peripheral blood lymphocyte subsets in healthy Turkish children. The Turkish Journal of Pediatrics. 2004;46:125–30.PubMed Ikincioğulları A, Kendirli T, Doğu F. Peripheral blood lymphocyte subsets in healthy Turkish children. The Turkish Journal of Pediatrics. 2004;46:125–30.PubMed
17.
Zurück zum Zitat Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatric Allergy and Immunology. 2008;19(4):298–302. doi:dx.doi.org.CrossRefPubMed Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatric Allergy and Immunology. 2008;19(4):298–302. doi:dx.​doi.​org.CrossRefPubMed
18.
Zurück zum Zitat Yorulmaz A, Artac H, Kara R, Keles S, Reisli I. Primer immün yetmezlikli 1054 olgunun retrospektif değerlendirilmesi. Astim Allerji Immunoloji. 2008;6:127–34. Yorulmaz A, Artac H, Kara R, Keles S, Reisli I. Primer immün yetmezlikli 1054 olgunun retrospektif değerlendirilmesi. Astim Allerji Immunoloji. 2008;6:127–34.
19.
Zurück zum Zitat Villartay JP, Schwarz K, Villa A. V(D)J recombination defects. In: Ochs HD, Smith CIE, Puck J, editors. Primary immunodeficiency diseases, vol. 2. New York: Oxford University Press; 2007. p. 153–68. Villartay JP, Schwarz K, Villa A. V(D)J recombination defects. In: Ochs HD, Smith CIE, Puck J, editors. Primary immunodeficiency diseases, vol. 2. New York: Oxford University Press; 2007. p. 153–68.
20.
Zurück zum Zitat Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2007;105:177–86.CrossRef Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2007;105:177–86.CrossRef
21.
Zurück zum Zitat Karaca NE, Aksu G, Genel F, Gulez N, Can S, Aydınok Y, et al. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID. Clinical and Experimental Medicine. 2009;9:339–42.CrossRefPubMed Karaca NE, Aksu G, Genel F, Gulez N, Can S, Aydınok Y, et al. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID. Clinical and Experimental Medicine. 2009;9:339–42.CrossRefPubMed
22.
Zurück zum Zitat Kato M, Kimura H, Seki M, Shimada A, Hayashi Y, Morio T, et al. Omenn syndrome—review of several phenotypes of Omenn syndrome and RAG1-RAG2 mutations in Japan. Allergology International. 2006;55:115–9.CrossRefPubMed Kato M, Kimura H, Seki M, Shimada A, Hayashi Y, Morio T, et al. Omenn syndrome—review of several phenotypes of Omenn syndrome and RAG1-RAG2 mutations in Japan. Allergology International. 2006;55:115–9.CrossRefPubMed
23.
Zurück zum Zitat Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, et al. Clinical and laboratory findings in hyper- IgM syndrome with novel CD40L and AICDA mutations. Journal of Clinical Immunology. 2009;29:769–76.CrossRefPubMed Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, et al. Clinical and laboratory findings in hyper- IgM syndrome with novel CD40L and AICDA mutations. Journal of Clinical Immunology. 2009;29:769–76.CrossRefPubMed
24.
Zurück zum Zitat Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82:373–84.CrossRefPubMed Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82:373–84.CrossRefPubMed
25.
Zurück zum Zitat Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, et al. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplantation. 2007;40(3):279–81.CrossRefPubMed Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, et al. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplantation. 2007;40(3):279–81.CrossRefPubMed
Metadaten
Titel
Consanguinity Rate and Delay in Diagnosis in Turkish Patients with Combined Immunodeficiencies: a Single-Center Study
verfasst von
Elif Azarsiz
Nesrin Gulez
Neslihan Edeer Karaca
Guzide Aksu
Necil Kutukculer
Publikationsdatum
01.02.2011
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2011
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9472-8

Weitere Artikel der Ausgabe 1/2011

Journal of Clinical Immunology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.